The Effect of Low and High Vacuum Drainage on the Postoperative Drainage of Breast Cancer: Insights from a Prospective, Non-Inferiority, Randomized Clinical Trial

Cancer Manag Res. 2020 Dec 3:12:12487-12496. doi: 10.2147/CMAR.S283031. eCollection 2020.

Abstract

Background: Vacuum drains have been extensively applied to prevent seroma formation after breast surgery. However, the usage of negative suction drainage is mainly determined by surgeon's experience and preferences. The aim of this study is to prospectively compare the drain effect after breast surgery between the low and high vacuum drains.

Methods: This prospectively randomized trial (from January 2018 to June 2019) involved 188 patients who were subjected to modified radical mastectomy (group A, n=128) or immediate breast reconstruction with implants (group B, n=60). In each group, patients were randomized to receive high vacuum drain (pressure=-98 kPa) or low vacuum drain (pressure=-12 kPa) after surgery. Days of drain permanence, which means the duration of drainage, was the primary endpoint.

Results: According to the comparison of days of drain permanence, the effect of a low vacuum drain is not inferior to a high vacuum drain in group A (pectoral drain, P<0.001; axillary drain, P<0.001) or group B (submuscular drain, P=0.002). The complications frequently occurred on patients with high vacuum drain (11.7%), such as seroma formation. The expense of low vacuum drain was significantly lower than high vacuum drain in both groups (P<0.01).

Conclusion: The drain effect of the low vacuum drain is not inferior to a high vacuum drain in both group A and group B. The low vacuum drain was effective, relatively cheap, and did not increase the incidence of complications; it is therefore more recommended after breast surgery.

Keywords: breast surgery; days of drain permanence; postoperative drain.

Publication types

  • Case Reports
  • Clinical Trial

Grants and funding

This work is supported by the National Key R&D Program of China (2017YFC1309103 and 2017YFC1309104); the Natural Science Foundation of China (81672594, 81772836, 81872139, 82072907 and 82003311); Clinical Innovation Project of Bioland Laboratory (Guangzhou Regenerative Medicine and Health Guangdong Laboratory, 2018GZR0201004); Sun Yat-Sen Memorial Hospital Cultivation Project for Clinical Research (SYS-C-201805, SYS-Q-202004); Key Projects of The National Natural Science Foundation of China (51861125203); Project of Roche Solid Tumor Research Foundation of Chinese Society of Clinical Oncology (Y-Roche2019/2-0078); Sun Yat-Sen Memorial Hospital Yat-Sen Scientific Research Launch Project (YXQH201920); and Medical Science and Technology Research Fund of Guangdong Province (A2020391).